Teleconference regarding interim report for the period January 1 - March 31, 2014
May 01, 2014 10:15 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Investor News no. 05-14 / Copenhagen, May 1, 2014
Topotarget announces that a teleconference regarding the Company’s interim report for the period January 1 – March...
HealthCap IV forpligter sig til at stemme for Topotargets påtænkte fusion med BioAlliance Pharma
April 29, 2014 10:37 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Investornyhed nr. 04-14 / København, 29. april 2014
Topotarget har modtaget følgende meddelelse fra sin storaktionær HealthCap-fondene:
Venturekapitalfonden...
HealthCap IV is committed to vote in support of Topotarget’s proposed merger with BioAlliance Pharma
April 29, 2014 10:37 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Investor News no. 04-14 / Copenhagen, April 29, 2014
Topotarget has received the following announcement from its major shareholder the HealthCap funds:
The venture...
Major shareholder announcement
April 28, 2014 04:53 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 08-14 / Copenhagen, April 28, 2014
Topotarget A/S today announced that the company has received a notification from the HealthCap funds stating that...
Storaktionærmeddelelse
April 28, 2014 04:53 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 08-14 / København, 28. april 2014
Topotarget A/S meddeler hermed, at selskabet har modtaget meddelelse fra HealthCap fondene om, at HealthCap fondenes...
Passing on Annual General Meeting
April 24, 2014 12:37 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 07-14 / Copenhagen, April 24, 2014
Topotarget A/S today held its annual general meeting at Symbion, Fruebjergvej 3, DK-2100 Copenhagen, Denmark.
At...
Forløb af Ordinær Generalforsamling
April 24, 2014 12:37 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 07-14 / København, 24. april 2014
Topotarget A/S afholdt i dag ordinær generalforsamling på adressen Symbion, Fruebjergvej 3, 2100 København Ø.
På...
Topotarget og BioAlliance Pharma indgår fusionsaftale for at skabe et nyt førende selskab inden for sjældne kræftsygdomme
April 16, 2014 00:01 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 06-14 / København, 16. april 2014
-- Det sammenlagte selskab ventes at have større skala og en bred pipeline af senfaseprodukter, der kan adressere...
Topotarget and BioAlliance Pharma enter into merger agreement to create a leading orphan oncology company
April 16, 2014 00:01 ET
|
Topotarget
To NASDAQ OMX Copenhagen A/S
Announcement no. 06-14 / Copenhagen, April 16, 2014
-- Combined company expected to have increased scale and a highly complementary pipeline of late-stage products...
Indkaldelse til Ordinær Generalforsamling 2014
March 28, 2014 07:34 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse nr. 05-14 / København, 28. marts 2014
Hermed indkaldes til ordinær generalforsamling i Topotarget A/S:
Torsdag den 24. april 2014 kl....